Sam Eldessouky - 11 Jun 2021 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: BHC
Reported as of: 11 Jun 2021
Net transaction value: -$538,586
SEC form: 4
Accepted by SEC: 15 Jun 2021, 16:11:51 UTC
Prior SEC filing: 03 Jun 2021
Next SEC filing: 02 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Kirsten O'Donnell, attorney-in-fact for Sam Eldessouky

Key filing fact

Sam Eldessouky filed Form 4 for Bausch Health Companies Inc. (BHC) on 15 Jun 2021.

Key facts

This page summarizes Sam Eldessouky's Form 4 filing for Bausch Health Companies Inc. (BHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2021, 16:11.

Change

Previous filing in this sequence was filed on 03 Jun 2021.
Current net transaction value: -$538,586.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Sale

Transaction value: $538,586
Shares: -17,000
Change %: -13%
Price: $31.68
Shares after: 116,857
Date: 11 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.67 to $31.711. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price.